Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
featured
Published in Primary Care and
1 other channel

Journal Scan / Research · August 12, 2015

Impact of Ezetimibe and Atorvastatin on Plaque Regression

Journal of the American College of Cardiology

 

 Save  Recommend
 Share

Additional Info

Journal of the American College of Cardiology
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial
J Am Coll Cardiol 2015 Aug 04;66(5)495-507, K Tsujita, S Sugiyama, H Sumida, H Shimomura, T Yamashita, K Yamanaga, N Komura, K Sakamoto, H Oka, K Nakao, S Nakamura, M Ishihara, K Matsui, N Sakaino, N Nakamura, N Yamamoto, S Koide, T Matsumura, K Fujimoto, R Tsunoda, Y Morikami, K Matsuyama, S Oshima, K Kaikita, S Hokimoto, H Ogawa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated